MANUFACTURERS LIFE INSURANCE COMPANY, THE - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$646,252
-36.2%
203,8650.0%0.00%
-100.0%
Q2 2023$1,013,209
+1.8%
203,865
+1.2%
0.00%0.0%
Q1 2023$994,946
-6.2%
201,406
+14.5%
0.00%0.0%
Q4 2022$1,061,127
-31.7%
175,914
+18.1%
0.00%0.0%
Q3 2022$1,553,773
-10.6%
148,998
-0.4%
0.00%0.0%
Q2 2022$1,738,273
+69.9%
149,645
+35.7%
0.00%0.0%
Q1 2022$1,023,393
+86.8%
110,243
+200.1%
0.00%
Q4 2021$548,000
-42.1%
36,739
-0.2%
0.00%
-100.0%
Q3 2021$946,000
-8.4%
36,810
-7.1%
0.00%0.0%
Q2 2021$1,033,000
-8.2%
39,618
+24.3%
0.00%0.0%
Q1 2021$1,125,000
+32.4%
31,867
-5.3%
0.00%0.0%
Q4 2020$850,000
-30.0%
33,662
+4.6%
0.00%0.0%
Q3 2020$1,214,000
-4.6%
32,182
+5.9%
0.00%0.0%
Q2 2020$1,272,000
+143.2%
30,390
+13.0%
0.00%0.0%
Q1 2020$523,000
-20.9%
26,885
+5.6%
0.00%0.0%
Q4 2019$661,000
-8.2%
25,450
-3.7%
0.00%0.0%
Q3 2019$720,000
+3.2%
26,426
+1.6%
0.00%0.0%
Q2 2019$698,000
+138.2%
25,999
+156.8%
0.00%
Q1 2019$293,00010,1240.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders